An international team of researchers estimates that about half of the world's seabirds have ingested plastic additives after studying 145 seafowls of 32 species from 16 areas of the world.
Plastic chemicals such as brominated flame retardants and ultraviolet absorbers were found in 76 of these, including three from the waters of Awashima island in Niigata Prefecture, which was polluted at mild concentrations.
Ultraviolet absorbers are used to prevent the sunlight-induced degradation of plastics.
Their findings appeared in the English-language journal of the Japan Society for Environmental Chemistry in October.
In addition to the seabirds, chemicals used in plastic products to prevent them from deteriorating or catching fire have been found in other wildlife, including hermit crabs and humans.
Experts are calling for closer studies to be conducted on countermeasures against pollution by plastic additives, which even very small quantities could have adverse health effects.
The researchers were mainly from Japan and the US.


Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO
U.S. Launches New Strikes on Iran as Trump Signals Peace Deal Uncertainty
Nikkei Hits Record High as AI Chip Stocks Power Japan Market Rally
New World Screwworm Found Near U.S. Border Raises Threat to Cattle Industry and Beef Prices
Parasites are ecological dark matter – and they need protecting
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
GesiaPlatform Launches Carbon-Neutral Lifestyle App ‘Net Zero Heroes’
S&P 500, Nasdaq Hit Record Highs as Iran Ceasefire Talks and AI Rally Boost Markets
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead
Oil Prices Fall as Markets Await U.S.-Iran Peace Deal Decision
European Stocks Rise as AI Optimism Offsets U.S.-Iran Tensions
Fungi are among the planet’s most important organisms — yet they continue to be overlooked in conservation strategies
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 



